. A mGluR5 antagonist under clinical development improves L-DOPA-induced dyskinesia in parkinsonian rats and monkeys. Neurobiol Dis. 2010 Sep;39(3):352-61. PubMed.

Recommends

Please login to recommend the paper.

Comments

Make a Comment

To make a comment you must login or register.

Comments on this content

No Available Comments

This paper appears in the following:

News

  1. Aβ Oligomers: A Fatal Attraction for Glutamate Receptors?